A citation-based method for searching scientific literature


List of co-cited articles
50 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial.
Alan J Garber, Allen B King, Stefano Del Prato, Seamus Sreenan, Mustafa K Balci, Manuel Muñoz-Torres, Julio Rosenstock, Lars A Endahl, Ann Marie Ocampo Francisco, Priscilla Hollander. Lancet 2012
226
66

AACE comprehensive diabetes management algorithm 2013.
Alan J Garber, Martin J Abrahamson, Joshua I Barzilay, Lawrence Blonde, Zachary T Bloomgarden, Michael A Bush, Samuel Dagogo-Jack, Michael B Davidson, Daniel Einhorn, W Timothy Garvey,[...]. Endocr Pract 2013
306
50


Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
Anushka Patel, Stephen MacMahon, John Chalmers, Bruce Neal, Laurent Billot, Mark Woodward, Michel Marre, Mark Cooper, Paul Glasziou, Diederick Grobbee,[...]. N Engl J Med 2008
50

Successful treatment of prediabetes in clinical practice: targeting insulin resistance and β-cell dysfunction.
John Armato, Ralph A DeFronzo, Muhammad Abdul-Ghani, Ron Ruby. Endocr Pract 2012
30
50


Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.
Benjamin M Scirica, Deepak L Bhatt, Eugene Braunwald, P Gabriel Steg, Jaime Davidson, Boaz Hirshberg, Peter Ohman, Robert Frederich, Stephen D Wiviott, Elaine B Hoffman,[...]. N Engl J Med 2013
33


Effects of exenatide on measures of β-cell function after 3 years in metformin-treated patients with type 2 diabetes.
Mathijs C Bunck, Anja Cornér, Bjorn Eliasson, Robert J Heine, Rimma M Shaginian, Marja-Riitta Taskinen, Ulf Smith, Hannele Yki-Järvinen, Michaela Diamant. Diabetes Care 2011
185
33

Sulfonylurea induced beta-cell apoptosis in cultured human islets.
Kathrin Maedler, Richard D Carr, Domenico Bosco, Richard A Zuellig, Thierry Berney, Marc Y Donath. J Clin Endocrinol Metab 2005
232
33


Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes.
Silvio E Inzucchi, Richard M Bergenstal, John B Buse, Michaela Diamant, Ele Ferrannini, Michael Nauck, Anne L Peters, Apostolos Tsapas, Richard Wender, David R Matthews. Diabetes Care 2015
33

10-year follow-up of intensive glucose control in type 2 diabetes.
Rury R Holman, Sanjoy K Paul, M Angelyn Bethel, David R Matthews, H Andrew W Neil. N Engl J Med 2008
33

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial.
Jean-Louis Chiasson, Robert G Josse, Ramon Gomis, Markolf Hanefeld, Avraham Karasik, Markku Laakso. Lancet 2002
33

Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.
David M Nathan, Patricia A Cleary, Jye-Yu C Backlund, Saul M Genuth, John M Lachin, Trevor J Orchard, Philip Raskin, Bernard Zinman. N Engl J Med 2005
33

Pramlintide improved glycemic control and reduced weight in patients with type 2 diabetes using basal insulin.
Matthew Riddle, Juan Frias, Bei Zhang, Holly Maier, Carl Brown, Karen Lutz, Orville Kolterman. Diabetes Care 2007
72
33

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.
John A Dormandy, Bernard Charbonnel, David J A Eckland, Erland Erdmann, Massimo Massi-Benedetti, Ian K Moules, Allan M Skene, Meng H Tan, Pierre J Lefèbvre, Gordon D Murray,[...]. Lancet 2005
33

Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6).
John B Buse, Julio Rosenstock, Giorgio Sesti, Wolfgang E Schmidt, Eduard Montanya, Jason H Brett, Marcin Zychma, Lawrence Blonde. Lancet 2009
33

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.
Steven E Kahn, Steven M Haffner, Mark A Heise, William H Herman, Rury R Holman, Nigel P Jones, Barbara G Kravitz, John M Lachin, M Colleen O'Neill, Bernard Zinman,[...]. N Engl J Med 2006
33

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
Silvio E Inzucchi, Richard M Bergenstal, John B Buse, Michaela Diamant, Ele Ferrannini, Michael Nauck, Anne L Peters, Apostolos Tsapas, Richard Wender, David R Matthews. Diabetes Care 2012
33

Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study.
Arne Astrup, Stephan Rössner, Luc Van Gaal, Aila Rissanen, Leo Niskanen, Mazin Al Hakim, Jesper Madsen, Mads F Rasmussen, Michael E J Lean. Lancet 2009
613
33



Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
William C Knowler, Elizabeth Barrett-Connor, Sarah E Fowler, Richard F Hamman, John M Lachin, Elizabeth A Walker, David M Nathan. N Engl J Med 2002
33




Effects of intensive glucose lowering in type 2 diabetes.
Hertzel C Gerstein, Michael E Miller, Robert P Byington, David C Goff, J Thomas Bigger, John B Buse, William C Cushman, Saul Genuth, Faramarz Ismail-Beigi, Richard H Grimm,[...]. N Engl J Med 2008
33

Glucose control and vascular complications in veterans with type 2 diabetes.
William Duckworth, Carlos Abraira, Thomas Moritz, Domenic Reda, Nicholas Emanuele, Peter D Reaven, Franklin J Zieve, Jennifer Marks, Stephen N Davis, Rodney Hayward,[...]. N Engl J Med 2009
33

Images in clinical medicine. Paget's disease of the mandible.
Mayank B Patel, Ashok Bhalla. N Engl J Med 2008
390
33

Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes.
Silvio E Inzucchi, Richard M Bergenstal, John B Buse, Michaela Diamant, Ele Ferrannini, Michael Nauck, Anne L Peters, Apostolos Tsapas, Richard Wender, David R Matthews. Diabetologia 2015
444
33


Efficacy and safety of sitagliptin monotherapy in Japanese patients with type 2 diabetes.
Kenji Nonaka, Taro Kakikawa, Asako Sato, Kotoba Okuyama, Go Fujimoto, Naoki Kato, Hideyo Suzuki, Yukio Hirayama, Tuli Ahmed, Michael J Davies,[...]. Diabetes Res Clin Pract 2008
156
33

Association between serious ischemic cardiac outcomes and medications used to treat diabetes.
David J Margolis, Ole Hoffstad, Brian L Strom. Pharmacoepidemiol Drug Saf 2008
81
33

Insulin action in brain regulates systemic metabolism and brain function.
André Kleinridders, Heather A Ferris, Weikang Cai, C Ronald Kahn. Diabetes 2014
285
33

AACE/ACE comprehensive diabetes management algorithm 2015.
Alan J Garber, Martin J Abrahamson, Joshua I Barzilay, Lawrence Blonde, Zachary T Bloomgarden, Michael A Bush, Samuel Dagogo-Jack, Michael B Davidson, Daniel Einhorn, Jeffrey R Garber,[...]. Endocr Pract 2015
159
33

Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic beta-cell mass and function in a rodent model of type 2 diabetes.
James Mu, John Woods, Yun-Ping Zhou, Ranabir Sinha Roy, Zhihua Li, Emanuel Zycband, Yue Feng, Lan Zhu, Cai Li, Andrew D Howard,[...]. Diabetes 2006
351
33

Mechanism of the mitogenic influence of hyperinsulinemia.
Boris Draznin. Diabetol Metab Syndr 2011
24
33

Further improvement in postprandial glucose control with addition of exenatide or sitagliptin to combination therapy with insulin glargine and metformin: a proof-of-concept study.
Sabine Arnolds, Sibylle Dellweg, Janina Clair, Marie-Paule Dain, Michael A Nauck, Klaus Rave, Christoph Kapitza. Diabetes Care 2010
139
33

Insulin resistance: pathophysiology and rationale for treatment.
Sergio Muntoni, Sandro Muntoni. Ann Nutr Metab 2011
20
33

Use of insulin and insulin analogs and risk of cancer - systematic review and meta-analysis of observational studies.
Oystein Karlstad, Jacob Starup-Linde, Peter Vestergaard, Vidar Hjellvik, Marloes T Bazelier, Marjanka K Schmidt, Morten Andersen, Anssi Auvinen, Jari Haukka, Kari Furu,[...]. Curr Drug Saf 2013
70
33


Hyperinsulinemic syndrome: the metabolic syndrome is broader than you think.
Christopher T Kelly, Janet Mansoor, G Lynis Dohm, William H H Chapman, John R Pender, Walter J Pories. Surgery 2014
26
33

Exenatide inhibits beta-cell apoptosis by decreasing thioredoxin-interacting protein.
Junqin Chen, Francesca M Couto, Alexandra H Minn, Anath Shalev. Biochem Biophys Res Commun 2006
80
33

The role of the kidneys in glucose homeostasis: a new path towards normalizing glycaemia.
R A DeFronzo, J A Davidson, S Del Prato. Diabetes Obes Metab 2012
316
33




Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
33



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.